文献速递重症综合管理与镇静镇痛

粪性腹膜炎与肺炎所致脓毒症转录组反应的共性与差异

Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01
一句话结论成人ICU脓毒症患者中,转录组反应大部分与感染源无关,粪性腹膜炎可识别出与早期死亡相关的两个脓毒症反应特征亚组。

该研究对收入ICU的成人粪性腹膜炎脓毒症患者(n=117)、社区获得性肺炎脓毒症患者(n=126)及无脓毒症对照(n=10)的外周血白细胞进行全基因组表达谱分析。结果显示约18%的转录基因组与对照相比存在差异表达,且不依赖感染源,真核起始因子2信号是最富集的经典通路。在粪性腹膜炎中识别出两个脓毒症反应特征(SRS)亚组,与早期死亡相关(P=0.01;风险比4.78),亚组归属在ICU住院期间动态变化。仅有少量基因(n=263)按感染源差异调控,富集于IFN信号和抗原提呈。作者认为多数转录组反应反映免疫状态和预后,为脓毒症分层和精准医学提供机会。

要点

  • 在粪性腹膜炎脓毒症患者中识别出两个SRS亚组,与早期死亡相关(P=0.01;风险比4.78)。
  • SRS亚组归属在ICU住院期间是动态变化的,连续采样可显示这种变化。
  • 约18%的转录基因组与无脓毒症对照相比存在差异表达,且不依赖感染源;真核起始因子2信号是最富集的经典通路。
  • 仅263个基因按感染源差异调控,富集于IFN信号和抗原提呈,提示感染源特异性有限。
  • SRS是转录组变异的主要预测因素,作者认为该发现为脓毒症患者分层和精准医学提供机会。

适用人群与场景

  • 收入ICU的成人脓毒症患者,感染源为粪性腹膜炎(n=117)或社区获得性肺炎(n=126)。
  • 对照为无脓毒症的受试者(n=10)。

研究设计与关键结果

  • 研究类型为基因表达谱分析(病例对照式比较),样本包括粪性腹膜炎脓毒症117例、社区获得性肺炎脓毒症126例、无脓毒症对照10例。
  • 约18%的转录基因组与对照相比存在差异表达,不依赖感染源,真核起始因子2信号是最富集的经典通路。
  • 在粪性腹膜炎中识别出两个SRS亚组,与早期死亡相关(P=0.01;风险比4.78)。
  • 定义了预测SRS分组的基因集,连续采样显示亚组归属在ICU住院期间是动态变化的。
  • SRS是转录组变异的主要预测因素;仅263个基因按感染源差异调控,富集于IFN信号和抗原提呈。
  • 从疾病 onset 起的时间变化涉及吞噬体形成、自然杀伤细胞和IL-3信号。

证据类型、等级与局限

  • 证据类型:基因表达谱分析研究(外周血白细胞全基因组表达谱)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,多数脓毒症转录组反应不依赖感染源,包含反映免疫状态和预后的特征,为患者分层和精准医学提供机会。
  • 在粪性腹膜炎脓毒症患者中,SRS亚组归属在ICU住院期间动态变化,提示单次采样可能不足以反映免疫状态变化。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Heterogeneity in the septic response has hindered efforts to understand pathophysiology and develop targeted therapies. Source of infection, with different causative organisms and temporal changes, might influence this heterogeneity.

OBJECTIVES: To investigate individual and temporal variations in the transcriptomic response to sepsis due to fecal peritonitis, and to compare these with the same parameters in community-acquired pneumonia.

METHODS: We performed genome-wide gene expression profiling in peripheral blood leukocytes of adult patients admitted to intensive care with sepsis due to fecal peritonitis (n = 117) or community-acquired pneumonia (n = 126), and of control subjects without sepsis (n = 10).

MEASUREMENTS AND MAIN RESULTS: A substantial portion of the transcribed genome (18%) was differentially expressed compared with that of control subjects, independent of source of infection, with eukaryotic initiation factor 2 signaling being the most enriched canonical pathway. We identified two sepsis response signature (SRS) subgroups in fecal peritonitis associated with early mortality (P = 0.01; hazard ratio, 4.78). We defined gene sets predictive of SRS group, and serial sampling demonstrated that subgroup membership is dynamic during intensive care unit admission. We found that SRS is the major predictor of transcriptomic variation; a small number of genes (n = 263) were differentially regulated according to the source of infection, enriched for IFN signaling and antigen presentation. We define temporal changes in gene expression from disease onset involving phagosome formation as well as natural killer cell and IL-3 signaling.

CONCLUSIONS: The majority of the sepsis transcriptomic response is independent of the source of infection and includes signatures reflecting immune response state and prognosis. A modest number of genes show evidence of specificity. Our findings highlight opportunities for patient stratification and precision medicine in sepsis.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Burnham KL, Davenport EE, Radhakrishnan J, et al. Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia. Am J Respir Crit Care Med. 2017. PMID: 28036233. doi:10.1164/rccm.201608-1685OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。